Shehnaaz Suliman's most recent trade in 10x Genomics Inc - Ordinary Shares - Class A was a trade of 15,357 Class A Common Stock done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics Inc - Ordinar... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 15,357 | 28,616 (0%) | 0% | 0 | Class A Common Stock | |
| Ultragenyx Pharmaceutical ... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 10,787 | 10,787 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,740 | 25,940 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 9,900 | 9,900 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 5,345 | 20,200 (0%) | 0% | 0 | Common Stock | |
| 10x Genomics Inc - Ordinar... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 8,649 | 13,259 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 4,661 | 4,661 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 1,865 | 4,610 (0%) | 0% | 0 | Class A Common Stock | |
| Ultragenyx Pharmaceutical ... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 7,110 | 7,110 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,860 | 14,855 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 6,245 | 6,245 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 3,300 | 10,995 (0%) | 0% | 0 | Common Stock | |
| 10x Genomics Inc - Ordinar... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 5,300 | 5,300 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 2,120 | 2,745 (0%) | 0% | 0 | Class A Common Stock | |
| Alector Inc | Shehnaaz Suliman | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.23 per share. | 10 Dec 2021 | 75,000 | 177,598 (0%) | 0% | 17.2 | 1,292,250 | Common Stock |
| Alector Inc | Shehnaaz Suliman | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2021 | 75,000 | 305,187 | - | - | Employee Stock Option (right to buy) | |
| Alector Inc | Shehnaaz Suliman | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2021 | 75,000 | 380,187 | - | - | Employee Stock Option (right to buy) | |
| Alector Inc | Shehnaaz Suliman | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.23 per share. | 10 Dec 2021 | 75,000 | 177,598 (0%) | 0% | 17.2 | 1,292,250 | Common Stock |
| Alector Inc | Shehnaaz Suliman | President and COO | Sale of securities on an exchange or to another person at price $ 21.69 per share. | 10 Dec 2021 | 66,126 | 111,472 (0%) | 0% | 21.7 | 1,433,975 | Common Stock |
| Alector Inc | Shehnaaz Suliman | President and COO | Sale of securities on an exchange or to another person at price $ 21.16 per share. | 10 Dec 2021 | 64,102 | 113,496 (0%) | 0% | 21.2 | 1,356,347 | Common Stock |
| Alector Inc | Shehnaaz Suliman | President and COO | Sale of securities on an exchange or to another person at price $ 21.73 per share. | 10 Dec 2021 | 10,898 | 102,598 (0%) | 0% | 21.7 | 236,802 | Common Stock |
| Alector Inc | Shehnaaz Suliman | President and COO | Sale of securities on an exchange or to another person at price $ 22.33 per share. | 10 Dec 2021 | 8,874 | 102,598 (0%) | 0% | 22.3 | 198,192 | Common Stock |
| Ultragenyx Pharmaceutical ... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 4,125 | 4,125 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 2,145 | 7,695 (0%) | 0% | 0 | Common Stock | |
| 10x Genomics Inc - Ordinar... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 1,563 | 1,563 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Shehnaaz Suliman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 625 | 625 (0%) | 0% | 0 | Class A Common Stock | |
| Alector Inc | Shehnaaz Suliman | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock |